Nifedipine acts as a dihydropyridine calcium channel blocker for cardiac health. By stabilizing smooth muscle cells, it promotes significant vasodilation of peripheral and coronary arteries, managing both pressure and angina.
Modulating vascular tone, nifedipine belongs to the dihydropyridine class of calcium-channel blockers. It acts primarily to relax smooth muscle in blood vessel walls, which lowers resistance to blood flow. This mechanism underlies its use for heart-related discomfort and high blood pressure. The substance appears as the active compound in medications such as Adalat and Procardia, which are approved for Singapore’s market by the Health Sciences Authority.
Presented as tablets or extended-release capsules, nifedipine powers medicines such as Adalat and Procardia. Common formulations include immediate-release tablets for rapid effect and once-daily extended-release capsules for steady control. In Singapore, both generic and brand-name versions coexist, each undergoing strict HSA evaluation for quality and safety. Patients may receive these products through pharmacies that dispense under a healthcare professional’s direction.
Alleviating chest discomfort, this agent finds use in several cardiovascular scenarios. It assists patients experiencing stable angina by improving blood flow to the heart muscle. It also contributes to the management of essential hypertension, where sustained vessel relaxation lowers systemic pressure. Peripheral circulation problems such as Raynaud’s phenomenon benefit from its vasodilating action. Additionally, certain esophageal spasm disorders respond to the smooth-muscle relaxation it provides.
Relaxing smooth muscle cells, it reduces calcium influx that drives vessel contraction. By blocking calcium channels on arterial walls, the drug diminishes the force of muscle contraction, allowing arteries to widen. This widening eases the workload on the heart and improves oxygen delivery to tissues. The effect appears within hours for immediate-release tablets and maintains a steadier profile with extended-release forms.
Mild reactions often appear as brief headache, facial flushing, or swelling of the ankles. These symptoms usually resolve without medical intervention and may lessen as the body adjusts.
Rare but serious events may include a sudden drop in blood pressure or abnormal heart rhythms. Prompt medical attention is advised if dizziness, fainting, or palpitations occur.
Patients with severe aortic stenosis, pregnancy, or known hypersensitivity should avoid this medication. These conditions heighten the risk of adverse cardiovascular effects.
Alcohol and certain antifungal or antibiotic groups can alter blood levels of the drug, making close monitoring important. Users should refer to the specific medication’s insert for a complete interaction list.
Storing tablets at room temperature, protected from moisture, ensures stability throughout their shelf life. Treatment duration varies: short courses may target episodic angina, while long-term therapy can address chronic hypertension. Differences in dosage strength and release profile between Adalat and Procardia mean each product follows its own guidance. For detailed usage, dosing, and administration, refer to the specific medication's clinical information.
This article provides an educational overview of nifedipine and does not constitute medical advice. Specific products such as Adalat and Procardia vary in dosage strength, formulation type, and usage instructions, so outcomes may differ. The publisher assumes no liability for any clinical decisions made based on this information. Patients should review the labeling that accompanies their medication and discuss any questions with a qualified healthcare professional.
